| 2009 JASN IMPACT FACTOR 7.689 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BASIC RESEARCH |



*Children's Hospital, University Medical Center, and
Institute of Physiology, University of Regensburg, Regensburg, Germany
Correspondence: Dr. Hayo Castrop, Institute of Physiology, University of Regensburg, Universitätsstrasse 31, 93040 Regensburg, Germany. Phone: +49-941-943-2967; Fax: +49-941-943-4315; E-mail: hayo{at}castrop.com
Received for publication November 11, 2009. The angiotensin receptor-associated protein (Atrap) interacts with angiotensin II (AngII) type 1 (AT1) receptors and facilitates their internalization in vitro, but little is known about the function of Atrap in vivo. Here, we detected Atrap expression in several organs of wild-type mice; the highest expression was in the kidney where it localized to the proximal tubule, particularly the brush border. There was no Atrap expression in the renal vasculature or juxtaglomerular cells. We generated Atrap-deficient (Atrap–/–) mice, which were viable and seemed grossly normal. Mean systolic BP was significantly higher in Atrap–/– mice compared with wild-type mice. Dose-response relationships of arterial BP after acute AngII infusion were similar in both genotypes. Plasma volume was significantly higher and plasma renin concentration was markedly lower in Atrap–/– mice compared with wild-type mice. 125I-AngII binding showed enhanced surface expression of AT1 receptors in the renal cortex of Atrap–/– mice, accompanied by increased carboanhydrase-sensitive proximal tubular function. In summary, Atrap–/– mice have increased arterial pressure and plasma volume. Atrap seems to modulate volume status by acting as a negative regulator of AT1 receptors in the renal tubules.
This article has been cited by other articles:
![]() |
Z. Zhang and V. J. Dzau Angiotensin II Type 1 Receptor-Associated Protein Is an Endogenous Inhibitor of Angiotensin II Type 1 Receptor Action in Cardiac Hypertrophy: Role in Check and Balance Hypertension, May 1, 2010; 55(5): 1086 - 1087. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673